Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
AERIE PHARMACEUTICALS INC (AERI)
|
|
Balance Sheet |
|
|
|
Standardized | As Reported |
Annual | Quarterly |
|
In millions, except per share items | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 | Jun-30-20 |
| 10-Q | 10-Q | 8-K | 8-K | 10-Q | 10-K | 10-Q | 10-Q |
Assets |
Cash and equivalents | 39.4 | 56.4 | 37.2 | 61.8 | 122.7 | 151.6 | 129.8 | 151.3 |
Short-term investments | 144.9 | 138.8 | 102.6 | 105.8 | 85.5 | 88.8 | 88.6 | 90.6 |
Accounts receivable, net | 68.1 | 63.6 | 68.8 | 64.6 | 46.2 | 56.0 | 46.8 | 43.1 |
Inventories | 47.0 | 40.2 | 40.4 | 30.1 | 28.3 | 27.1 | 20.8 | 19.1 |
Other current assets | 12.0 | 17.9 | 106.6 | 13.7 | 10.9 | 8.3 | 9.1 | 9.0 |
Total current assets | 311.4 | 317.0 | 355.7 | 276.0 | 293.6 | 331.8 | 295.2 | 313.1 |
Property, plant, and equipment, net | 50.8 | 51.2 | 51.5 | 51.7 | 53.3 | 54.3 | 55.3 | 56.2 |
Long-term investments | | 4.0 | | | | | | |
Other fixed assets | 1.5 | 1.5 | 1.6 | 1.0 | 2.6 | 1.9 | 1.1 | 1.1 |
Total assets | 385.3 | 395.5 | 431.4 | 351.8 | 362.7 | 402.0 | 366.7 | 385.3 |
|
Accounts payable | 9.3 | 7.9 | 8.3 | 8.1 | 6.5 | 8.8 | 4.5 | 6.7 |
Accrued expenses | 105.6 | 103.0 | 112.3 | 106.1 | 82.8 | 90.7 | 78.8 | 71.9 |
Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Other current liabilities | 4.7 | 4.5 | 4.4 | 3.9 | 4.1 | 4.9 | 5.3 | 5.3 |
Total current liabilities | 119.7 | 115.3 | 125.0 | 118.1 | 93.4 | 104.5 | 88.6 | 83.9 |
Long-term debt | 312.1 | 311.7 | 234.5 | 228.2 | 216.1 | 210.4 | 204.7 | 199.2 |
Other liabilities | 94.7 | 94.3 | 89.2 | 78.4 | 63.6 | 63.2 | 13.3 | 12.4 |
Total liabilities | 526.5 | 521.3 | 448.7 | 424.7 | 373.1 | 378.1 | 306.6 | 295.4 |
|
Shareholders' equity [+] | -141.1 | -125.7 | -17.3 | -72.9 | -10.4 | 24.0 | 60.1 | 89.8 |
Paid-in capital | 1,020.8 | 1,016.5 | 1,136.7 | 1,126.6 | 1,110.7 | 1,103.1 | 1,093.0 | 1,083.0 |
Retained earnings | -1,161.2 | -1,141.8 | -1,153.9 | -1,199.4 | -1,121.1 | -1,079.1 | -1,033.0 | -993.3 |
Tangible shareholders' equity | -141.1 | -125.7 | -17.3 | -72.9 | -10.4 | 24.0 | 60.1 | 89.8 |
|